{"resourceType":"Parameters","id":"ImmDS-2013-0491","parameter":[{"name":"assessmentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0491","name":[{"family":"#2 @ 16 years, MCV4\nEvaluation_Test_Type: Age: At Recommended\nGeneral_Description: This test case describes when dose #1 and dose #2 of a Mening vaccine are administered at the recommended ages (11 and 16 years), that the doses are considered valid.  The series is complete."}],"gender":"female","birthDate":"2004-06-29","contact":[{"organization":{"reference":"Organization/FakeHospital"}}]}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0491-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"114","display":"MENACTRA"},{"system":"http://hl7.org/fhir/v2/0227","code":"PMC","display":"MENACTRA"}]},"patient":{"reference":"Patient/2013-0491"},"occurrenceDateTime":"2015-06-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0491-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"114","display":"MENACTRA"},{"system":"http://hl7.org/fhir/v2/0227","code":"PMC","display":"MENACTRA"}]},"patient":{"reference":"Patient/2013-0491"},"occurrenceDateTime":"2020-06-29T00:00:00.000"}}]}